JPMA Extends Suspension of Activities for Takeda as It Awaits Ruling of Administrative Authority on Blopress Scandal

The Japan Pharmaceutical Manufacturers Association (JPMA) decided to extend the suspension of Takeda Pharmaceutical’s official activities along with its representation among the JPMA’s vice presidents for a further two months at a general meeting on May 28. This measure was...read more